Compare AYTU & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AYTU | FOXX |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5M | 16.9M |
| IPO Year | N/A | N/A |
| Metric | AYTU | FOXX |
|---|---|---|
| Price | $2.33 | $5.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | 52.7K | ★ 2.9M |
| Earning Date | 11-13-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $63,696,000.00 | $63,030,415.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $47.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 139.29 |
| 52 Week Low | $0.95 | $1.71 |
| 52 Week High | $2.82 | $11.00 |
| Indicator | AYTU | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 51.73 |
| Support Level | $2.05 | $3.81 |
| Resistance Level | $2.39 | $6.30 |
| Average True Range (ATR) | 0.10 | 1.20 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 78.57 | 45.50 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.